Psoriatic Arthritis
Article
Swollen joints better predict ultrasound-defined inflammation in PsA than tender joints
Article
Risk for serious infection lower in patients with PsA vs. RA treated with TNF inhibitors
Article
PsA: Long-term benefits of upadacitinib in patients with inadequate response to biologics
Conference Coverage
Serious infection hospitalizations have declined in patients with PsA
Sepsis, urinary tract infections, and skin and soft-tissue infections declined among patients with PsA from 2012 to 2017 in the National Inpatient...
Conference Coverage
Tofacitinib postmarketing trial data shed light on JAK inhibitor risks
Analyses of the phase 3b/4 ORAL Surveillance trial results found independent factors for risk for major adverse cardiovascular events, cancer, and...
Conference Coverage
Risankizumab outperforms placebo at 6 months for psoriatic arthritis
At the 24-week assessment, participants receiving risankizumab showed greater improvement in primary and secondary endpoints than did placebo with...
From the Journals
Higher odds for preterm, C-section births seen in women with PsA
Pregnant women with psoriatic arthritis may have an increased risk for preterm birth or cesarean delivery if they are receiving antirheumatic...